Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

MetroCorp Bancshares Q2 Profit Rises - Quick Facts

MetroCorp Bancshares Inc. (MCBI: Quote) reported that its second-quarter net income applicable to common stock was $2.8 million, compared to $2.5 million in the year-ago period. Earnings per share for the quarter was $0.15, down from $0.16 in the comparable quarter last year.

On average, three analysts polled by Thomson Reuters expected the company to earn $0.15 per share for the quarter. Analysts' estimates typically exclude special items.

Net interest income for the latest second quarter was $12.98 million, down 4.9% compared with $13.65 million in the year-ago period, while total non-interest income rose 10.5% to $1.9 million from $1.8 million in the prior year quarter.

The decrease in net interest income was primarily due to a decline in the yield on loans, partially offset by lower cost of deposits.

Click here to receive FREE breaking news email alerts for MetroCorp Bancshares Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Firms responding to a survey by the Federal Reserve Bank of Philadelphia indicated continued growth in regional manufacturing activity in September, although the bank said the index of activity in the sector fell from its relatively high reading in August. Stocks have moved mostly higher in early trading on Thursday, extending a recent upward move by the markets. The major averages have all climbed into positive territory, with the Dow reaching a new record intraday high. With new construction of multi-family homes showing a substantial pullback, the Commerce Department released a report on Thursday showing a much steeper than expected drop in U.S. housing starts in the month of August.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.